Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Insomnia: full-pipeline trial registry
62 of 152 indexed Insomnia trials are currently recruiting.
Corpus placement: #74 of 28,707 conditions by registered trial count.
152 US clinical trials · 62 currently recruiting · #74 of 28,707 conditions by registered trial count
Insomnia: 152 US clinical trials tracked, 62 recruiting.
Insomnia is the subject of 152 registered US clinical trials on ClinicalTrials.gov, 62 of them currently open to new participants. 17 are in Phase 3-4 (later-stage) and 21 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 9 of these trials.
Enrollment posture brief
Registry condition insomnia
OPEN 62 | RECR 41% | LATE 17 | EARLY 21 | RANK #74 | SPON 9
Volume-matched condition peers
Nearest open-share peer: Brain Injuries, Traumatic (41% recruiting · 22 trials)
Insomnia lists 62 open slots (41% of 152 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Insomnia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Insomnia is recruiting above its size-band peers.
62 of 152 indexed trials (40.8%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Insomnia trials is spread across many organizations.
VA Office of Research and Development accounts for 9 of 152 trials (5.9%). 86 distinct sponsors appear on at least one study for this condition label.
-
Typical Insomnia enrolment sits around 80 participants.
Median target enrolment is 80 among the 152 trials that report a genuine target (sentinel values excluded). 85 of those (55.9%) plan for fewer than 100 participants.
-
Insomnia research is mostly interventional.
147 interventional and 5 observational studies make up this index (96.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
152 total, page 2 of 4
Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients
Massachusetts General Hospital
NCT06375265
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
NCT07191119
Digital Cognitive Behavioral Treatment of Insomnia in Youth: An RCT Examining Feasibility, Acceptability, and Efficacy of NiteCAPP Jr
University of South Florida
NCT07091149
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
Georgetown University
NCT07128927
Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep
University of Kansas Medical Center
NCT06840444
Mindfulness Meditation for Insomnia
Brigham and Women's Hospital
NCT06972303
Treating Insomnia in Mild Cognitive Impairment
Beth Israel Deaconess Medical Center
NCT06687161
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
Indiana University
NCT06541886
Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder
University of California, Los Angeles
NCT05499741
Novel Adaptive Cognitive Training in Autistic Adults with Co-occurring Insomnia
University of South Florida
NCT06291298
CBTi for the Treatment of Insomnia in Type 1 Diabetes
University of Illinois at Chicago
NCT07091318
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
Massachusetts General Hospital
NCT07417163
The Assessment of Human Sleep and Its Functions
StimScience
NCT07211646
National Adaptive Trial for PTSD Related Insomnia
VA Office of Research and Development
NCT03668041
Perinatal Research on Improving Sleep and Mental Health
University of California, San Francisco
NCT05596318
Remote STATE Training for Insomnia in Older Adults
Posit Science Corporation
NCT06589024
Intervention for Sleep and Pain in Youth: a Randomized Controlled Trial
Seattle Children's Hospital
NCT04936321
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
ProofPilot
NCT04627480
CBT-I to Improve Functional Outcomes in Veterans With Psychosis
VA Office of Research and Development
NCT04646200
Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)
University of Michigan
NCT04457674
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE)
Henry Ford Health System
NCT05356364
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
NCT00488072
Neurotechnology Following Traumatic Brain Injury
Brain State Technologies
NCT03649958
Solriamfetol and CBT-I in Patients With Insomnia Disorder
University of Pennsylvania
NCT05838430
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
University of Washington
NCT06392789
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
Brigham and Women's Hospital
NCT05991492
Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study
University of Kansas Medical Center
NCT07008924
Comparing Virtual Yoga to Standard Care on Insomnia Among Cancer Survivors
University of Rochester
NCT04458194
Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders
University of Arizona
NCT03540745
Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study
Stanford University
NCT02037438
Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors
University of Rochester NCORP Research Base
NCT02613364
A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
Sumitomo Pharma America
NCT00368030
Hypertension With Unsatisfactory Sleep Health
University of Pittsburgh
NCT02508129
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
Sumitomo Pharma America
NCT00235508
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
GlaxoSmithKline
NCT00280423
Reducing Health Disparities for Black Women in the Treatment of Insomnia
Boston University
NCT03613519
Sleep Healthy Using The Internet for Older Adult Sufferers of Insomnia and Sleeplessness
University of Virginia
NCT03213132
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
Sumitomo Pharma America
NCT00857220
Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire
Dayzz Live Well
NCT03468400
Research on Expecting Moms and Sleep Therapy
University of California, San Francisco
NCT02805998
Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia
University of Pennsylvania
NCT03774810
Impact of Sleep Workshops in College Students
NYU Langone Health
NCT02665247
Safety and Efficacy Study of APD125 in Patient With Insomnia
Arena Pharmaceuticals
NCT00452179
Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)
Henry Ford Health System
NCT05523726
Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy
Memorial Sloan Kettering Cancer Center
NCT02356575
Treatments for Insomnia: Mediators, Moderators and Quality of Life
Palo Alto Veterans Institute for Research
NCT02117388
Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
University of Washington
NCT03534284
Dual Treatment of Chronic Pain and Insomnia
Mary Free Bed Rehabilitation Hospital
NCT05033418
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
Massachusetts General Hospital
NCT03818581
Optimizing Efficiency and Impact of Digital Health Interventions for Caregivers
University of Virginia
NCT04986904
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 16 |
| Phase 3 | 5 |
| Phase 4 | 12 |
Top Sponsors
Named interventions
Most-linked intervention names on Insomnia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Insomnia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Insomnia page
152 registered trials, 62 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 62 Insomnia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- VA Office of Research and Development sponsors the most Insomnia trials on record, review their full trial history before evaluating a specific study. See VA Office of Research and Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Insomnia condition card totals 152 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.